BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15735477)

  • 1. Can we alter the natural history of Crohn disease in children?
    Hyams JS; Markowitz JF
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):262-72. PubMed ID: 15735477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.
    Lichtenstein GR
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S23-9. PubMed ID: 11380040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab for pediatric Crohn's disease.
    Hoffman I; Vermeire S; Van Assche G; Rutgeerts P
    Drugs Today (Barc); 2008 Aug; 44(8):615-28. PubMed ID: 18846272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease.
    Thayu M; Markowitz JE; Mamula P; Russo PA; Muinos WI; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):220-2. PubMed ID: 15699701
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenetics in inflammatory bowel disease.
    Pierik M; Rutgeerts P; Vlietinck R; Vermeire S
    World J Gastroenterol; 2006 Jun; 12(23):3657-67. PubMed ID: 16773681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
    Paré P
    Can J Gastroenterol; 2001 Nov; 15(11):751-6. PubMed ID: 11727005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
    Brookes MJ; Green JR
    Drugs; 2004; 64(10):1069-89. PubMed ID: 15139787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Melliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2005 Jun; 11(6):618-20. PubMed ID: 15905713
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
    Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
    Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing complicated Crohn's disease in children and adolescents.
    Homan M; Baldassano RN; Mamula P
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):572-9. PubMed ID: 16327836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease].
    Bastida Paz G; Nos Mateu P; Aguas Peris M; Beltrán Niclós B; Rodríguez Soler M; Ponce García J
    Gastroenterol Hepatol; 2007 Nov; 30(9):511-6. PubMed ID: 17980127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
    Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
    [No Abstract]   [Full Text] [Related]  

  • 16. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Meliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2004 Jul; 10(4):436-7. PubMed ID: 15475754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab and azathioprine: bridge or parachute?
    Travis S
    Gastroenterology; 2006 Apr; 130(4):1354-7. PubMed ID: 16618428
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral neuropathy with infliximab therapy in inflammatory bowel disease.
    Burger DC; Florin TH
    Inflamm Bowel Dis; 2009 Dec; 15(12):1772. PubMed ID: 19170193
    [No Abstract]   [Full Text] [Related]  

  • 19. Maintenance drugs for inflammatory bowel disease.
    Drug Ther Bull; 2001 Dec; 39(12):91-5. PubMed ID: 11799594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.